Sodium butyrate improves the effects of brain injury in a small-for-gestational-age rat model by activating the JAK1/STAT3 pathway
Journal of Neuropathology & Experimental Neurology · 2026
DOI: 10.1093/jnen/nlaf085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2026. Verfasst von Rui Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Children's Medical Center, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Janus Kinase 1, STAT3 Transcription Factor, Butyric Acid, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Beijing Natural Science Foundation-Haidian Original Innovation Joint Fund, Natural Science Foundation of Ningxia Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
The mechanisms of cognitive impairment in small-for-gestational-age (SGA) infants remain unclear. We investigated clinical effects and mechanisms of sodium butyrate (NaB) treatment in a SGA rat model. Behavioral tests, immunohistochemistry, and molecular biology analysis were performed on controls and on SGA rats divided into SGA, SGA + NaB, and SGA + NaB + upadacitinib (a JAK1 inhibitor) groups. Compared to the controls, SGA rats showed weakened neuroreflexes, impaired short-term learning and memory, and manifestations of anxiety and depression. Hippocampal neurons were damaged and apoptotic, and expression of pro-inflammatory factors IL-6 and TNF-α and the JAK1/STAT3 inflammatory pathway were increased in the SGA rats. NaB improved neuroreflexes, learning and memory, anxiety and depressive behaviors, and apoptosis of hippocampal neurons in SGA rats whereas NaB + upadacitinib treatment did not significantly improve these indicators. NaB upregulated JAK1/STAT3 pathway expression in hippocampal neurons of SGA rats and downregulated IL-6 and TNF-α expression; NaB + upadacitinib treatment had the opposite effects. Thus, NaB improved the neurobehavioral performance of SGA rats and reduced damage of hippocampal neurons by activating the JAK1/STAT3 pathway. This study reveals a mechanism of cognitive impairment in SGA infants, providing possible new therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Medical Center, Peking University First Hospital, Beijing, China.
Förderung
- Beijing Natural Science Foundation-Haidian Original Innovation Joint Fund
- Natural Science Foundation of Ningxia Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, R., Chen, X., Shen, Q., Liu, L., Hou, X., & Liu, N. (2026). Sodium butyrate improves the effects of brain injury in a small-for-gestational-age rat model by activating the JAK1/STAT3 pathway. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlaf085
Vancouver
Zhang R, Chen X, Shen Q, Liu L, Hou X, Liu N. Sodium butyrate improves the effects of brain injury in a small-for-gestational-age rat model by activating the JAK1/STAT3 pathway. Journal of Neuropathology & Experimental Neurology. 2026. doi:10.1093/jnen/nlaf085
BibTeX
@article{Zhang2026,
author = {Zhang, Rui and Chen, Xiaona and Shen, Qiuyue and Liu, Lili and Hou, Xinlin and Liu, Nana},
title = {Sodium butyrate improves the effects of brain injury in a small-for-gestational-age rat model by activating the JAK1/STAT3 pathway},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2026},
doi = {10.1093/jnen/nlaf085}
}
EUVIMED